DTIL vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 09, 2026

DTIL

43.8
AI Score
VS
DTIL Wins

CBIO

36.1
AI Score

Investment Advisor Scores

DTIL

44score
Recommendation
HOLD

CBIO

36score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric DTIL CBIO Winner
Revenue 10.84M 1.04M DTIL
Net Income -51.09M -48.12M CBIO
Net Margin -471.4% -4631.4% DTIL
Operating Income -28.24M -51.09M DTIL
ROE -112.8% -29.5% CBIO
ROA -40.6% -26.3% CBIO
Total Assets 125.92M 182.76M CBIO
Cash 86.08M 171.59M CBIO
Current Ratio 12.82 9.66 DTIL

Relative Price Performance (Last 90 Days)

DTIL 1M: -3.4% · 3M: +16.2% CBIO 1M: +18.1% · 3M: +5.8%

Current Technical Phase

DTIL

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 38

RSI (14): 37.9 · Price: $7.17

CBIO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.8% over 20 days), RSI 58

RSI (14): 58.0 · Price: $19.41

Fundamentals Snapshot

Metric DTIL CBIO
Market Cap
Forward P/E -3.9 -7.4
Trailing P/E
Revenue (TTM)
Revenue Growth 372.7% 0.0%
Gross Margin 1.0% 1.0%
Operating Margin -0.8% -14.3%
EPS -1.32 -0.14
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, DTIL is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.